Unlock Productivity In mAb Production: Upstream And Downstream Intensification

Increasing demand for monoclonal antibodies (mAbs) requires manufacturers to continually seek strategies for process optimization and intensification. New approaches in upstream and downstream processing are available to significantly boost productivity while simultaneously decreasing operational complexity and cost.

You can achieve higher yields and faster turnaround times by adopting high-density cell banking, optimizing media and feed systems, and integrating modern single-use technologies and automation throughout the workflow. Downstream, novel strategies like in-line dilution, strategic resin selection, and utilizing flow-through mode can provide substantial economic value and streamline purification steps.

Discover how these advancements can help you reduce manufacturing steps, minimize facility footprint, and accelerate your overall time to market. Access the on-demand webinar to learn how to intensify your mAb process for maximum productivity.